# This Randomized Controlled Trial Evaluates the Comparative Efficacy of Intravenous Meropenem Alone Versus Intravenous Meropenem Combined With Oral Azithromycin in Children Aged 6 Months to Under 5 Years Diagnosed With Blood Culture-confirmed Extensively Drug-resistant Uncomplicated Typhoid Fever

> **NCT07445282** · PHASE4 · COMPLETED · sponsor: **Sheikh Zayed Medical College** · enrollment: 90 (actual)

## Conditions studied

- Extensively Drug-Resistant Typhoid Fever
- Typhoid Fever
- Salmonella Typhi Infection

## Interventions

- **DRUG:** Meropenem
- **DRUG:** Azithromycin + Metronidazole

## Key facts

- **NCT ID:** NCT07445282
- **Lead sponsor:** Sheikh Zayed Medical College
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-05-14
- **Primary completion:** 2025-11-14
- **Final completion:** 2025-11-14
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2026-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07445282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07445282, "This Randomized Controlled Trial Evaluates the Comparative Efficacy of Intravenous Meropenem Alone Versus Intravenous Meropenem Combined With Oral Azithromycin in Children Aged 6 Months to Under 5 Years Diagnosed With Blood Culture-confirmed Extensively Drug-resistant Uncomplicated Typhoid Fever". Retrieved via AI Analytics 2026-07-14 from https://api.ai-analytics.org/clinical/NCT07445282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*